Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants

Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants

We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2006-09, Vol.43 (5), p.e42-e45
Hauptverfasser: Hageman, Jeffrey C., Liedtke, Laura A., Sunenshine, Rebecca H., Strausbaugh, Larry J., McDonald, L. Clifford, Tenover, Fred C.
Format: Artikel
Sprache:eng
Schlagworte:
Anti-Bacterial Agents - therapeutic use
Bacteremia - drug therapy
Bacteria
Blood diseases
Data Collection
Disease management
Drug resistance
Humans
Infection Control Practitioners
Methicillin Resistance
Staphylococcal Infections - drug therapy
Staphylococcus aureus - drug effects
Staphylococcus aureus - isolation & purification
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations approaching the limit of the susceptible range, most consultants indicated that they would switch to newer antimicrobial agents for treatment.
ISSN:1058-4838
1537-6591
DOI:10.1086/506568